Rachel Roche1,2, Ruth Simmons3,4, Alison F Crawshaw5,6, Pip Fisher7, Manish Pareek8, Will Morton9, Theresa Shryane10, Kristina Poole10, Arpana Verma7, Ines Campos-Matos5,11, Sema Mandal3,4. 1. Blood Safety, Hepatitis, Sexually Transmitted Infections (STI) and HIV Service, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK. rachel.roche@phe.gov.uk. 2. The National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Blood Borne and Sexually Transmitted Infections at University College London, Gower St, London, WC1E 6BT, UK. rachel.roche@phe.gov.uk. 3. Blood Safety, Hepatitis, Sexually Transmitted Infections (STI) and HIV Service, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK. 4. The National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Blood Borne and Sexually Transmitted Infections at University College London, Gower St, London, WC1E 6BT, UK. 5. Migration Health, Health Improvement, Public Health England, Wellington House, 133-155 Waterloo Road, London, SE1 8UG, UK. 6. Institute for Infection and Immunity, St George's, University of London, Cranmer Terrace, Tooting, London, SW17 0RE, UK. 7. University of Manchester, Oxford Road, Manchester, M13 9PL, UK. 8. Department of Respiratory Sciences, University of Leicester, University Road, Leicester, LE1 7RH, UK. 9. Public Health England Yorkshire and the Humber, 2nd Floor, Blenheim House, Duncombe Street, Leeds, LS1 4PL, UK. 10. Public Health England North West, 2nd Floor, 3 Piccadilly Place, London Road, Manchester, M1 3BN, UK. 11. Institute of Epidemiology and Healthcare, University College London (UCL), 1-19 Torrington Place WC1E 7HB, London, UK.
Abstract
BACKGROUND: UK migrants born in intermediate to high prevalence areas for blood borne viruses (BBV) including hepatitis B, hepatitis C and HIV are at increased risk of these infections. National guidance from Public Health England (PHE) and National Institute for Health and Care Excellence (NICE) recommends primary care test this population to increase diagnoses and treatment. We aimed to investigate primary care professionals' knowledge of entitlements, and perceptions of barriers, for migrants accessing healthcare, and their policies, and reported practices and influences on provision of BBV testing in migrants. METHODS: A pre-piloted questionnaire was distributed between October 2017 and January 2018 to primary care professionals attending the Royal College of General Practitioners and Best Practice in Primary Care conferences, via a link in PHE Vaccine Updates and through professional networks. Survey results were analysed to give descriptive statistics, and responses by respondent characteristics: profession, region, practice size, and frequency of seeing migrant patients. Responses were considered on a per question basis with response rates for each question presented with the results. RESULTS: Four hundred fourteen questionnaires were returned with responses varying by question, representing an estimated 5.7% of English GP practices overall. Only 14% of respondents' practices systematically identified migrant patients for testing. Universal opt-out testing was offered to newly registering migrant patients by 18% of respondents for hepatitis B, 17% for hepatitis C and 21% for HIV. Knowledge of healthcare entitlements varied; fewer clinical staff knew that general practice consultations were free to all migrants (76%) than for urgent care (88%). Performance payment structure (76%) had the greatest reported influence on testing, followed by PHE and Clinical Commissioning Group recommendations (73% each). Language and culture were perceived to be the biggest barriers to accessing care. CONCLUSIONS: BBV testing for migrant patients in primary care is usually ad hoc, which is likely to lead to testing opportunities being missed. Knowledge of migrants' entitlements to healthcare varies and could affect access to care. Interventions to improve professional awareness and identification of migrant patients requiring BBV testing are needed to reduce the undiagnosed and untreated burden of BBVs in this vulnerable population.
BACKGROUND: UK migrants born in intermediate to high prevalence areas for blood borne viruses (BBV) including hepatitis B, hepatitis C and HIV are at increased risk of these infections. National guidance from Public Health England (PHE) and National Institute for Health and Care Excellence (NICE) recommends primary care test this population to increase diagnoses and treatment. We aimed to investigate primary care professionals' knowledge of entitlements, and perceptions of barriers, for migrants accessing healthcare, and their policies, and reported practices and influences on provision of BBV testing in migrants. METHODS: A pre-piloted questionnaire was distributed between October 2017 and January 2018 to primary care professionals attending the Royal College of General Practitioners and Best Practice in Primary Care conferences, via a link in PHE Vaccine Updates and through professional networks. Survey results were analysed to give descriptive statistics, and responses by respondent characteristics: profession, region, practice size, and frequency of seeing migrant patients. Responses were considered on a per question basis with response rates for each question presented with the results. RESULTS: Four hundred fourteen questionnaires were returned with responses varying by question, representing an estimated 5.7% of English GP practices overall. Only 14% of respondents' practices systematically identified migrant patients for testing. Universal opt-out testing was offered to newly registering migrant patients by 18% of respondents for hepatitis B, 17% for hepatitis C and 21% for HIV. Knowledge of healthcare entitlements varied; fewer clinical staff knew that general practice consultations were free to all migrants (76%) than for urgent care (88%). Performance payment structure (76%) had the greatest reported influence on testing, followed by PHE and Clinical Commissioning Group recommendations (73% each). Language and culture were perceived to be the biggest barriers to accessing care. CONCLUSIONS: BBV testing for migrant patients in primary care is usually ad hoc, which is likely to lead to testing opportunities being missed. Knowledge of migrants' entitlements to healthcare varies and could affect access to care. Interventions to improve professional awareness and identification of migrant patients requiring BBV testing are needed to reduce the undiagnosed and untreated burden of BBVs in this vulnerable population.
Entities:
Keywords:
Blood borne virus; General practice; HIV; Healthcare access; Hepatitis B; Hepatitis C; Migrants; Screening; Testing; UK
Authors: Werner Leber; Heather McMullen; Jane Anderson; Nadine Marlin; Andreia C Santos; Stephen Bremner; Kambiz Boomla; Sally Kerry; Danna Millett; Sifiso Mguni; Sarah Creighton; Jose Figueroa; Richard Ashcroft; Graham Hart; Valerie Delpech; Alison Brown; Graeme Rooney; Maria Sampson; Adrian Martineau; Fern Terris-Prestholt; Chris Griffiths Journal: Lancet HIV Date: 2015-04-28 Impact factor: 12.767
Authors: Anne C Moorman; Jian Xing; Stephen Ko; Loralee B Rupp; Fujie Xu; Stuart C Gordon; Mei Lu; Philip R Spradling; Eyasu H Teshale; Joseph A Boscarino; Vinutha Vijayadeva; Mark A Schmidt; Scott D Holmberg Journal: Hepatology Date: 2015-03-20 Impact factor: 17.425
Authors: Rahma Elmahdi; Sarah M Gerver; Gabriela Gomez Guillen; Sarah Fidler; Graham Cooke; Helen Ward Journal: Sex Transm Infect Date: 2014-01-09 Impact factor: 3.519
Authors: Abby M Falla; Irene K Veldhuijzen; Amena A Ahmad; Miriam Levi; Jan Hendrik Richardus Journal: BMC Health Serv Res Date: 2017-02-20 Impact factor: 2.655
Authors: Helen Eborall; Fatimah Wobi; Kate Ellis; Janet Willars; Ibrahim Abubakar; Chris Griffiths; Manish Pareek Journal: EClinicalMedicine Date: 2020-04-18
Authors: Anu Jain; Albert J van Hoek; Jemma L Walker; Rohini Mathur; Liam Smeeth; Sara L Thomas Journal: PLoS One Date: 2017-11-30 Impact factor: 3.240